摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(p-chlorophenyl)-3-cyclohexen-1-one | 36716-75-3

中文名称
——
中文别名
——
英文名称
4-(p-chlorophenyl)-3-cyclohexen-1-one
英文别名
4-(4-Chlorophenyl)cyclohex-3-en-1-one
4-(p-chlorophenyl)-3-cyclohexen-1-one化学式
CAS
36716-75-3
化学式
C12H11ClO
mdl
——
分子量
206.672
InChiKey
GAXFKHSPCKYIGD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:76782ae122bcaceeada31f0855b2477d
查看

反应信息

  • 作为反应物:
    描述:
    4-(p-chlorophenyl)-3-cyclohexen-1-one 在 palladium 10% on activated carbon 、 氢气 作用下, 以 乙酸乙酯 为溶剂, 反应 16.0h, 生成 4-(4-氯苯基)环己酮
    参考文献:
    名称:
    Aryl extensions of thienopyrimidinones as fibroblast growth factor receptor 1 kinase inhibitors
    摘要:
    Optimization of thienopyrimidinone derivatives as FGFR1 kinase inhibitors is being pursued. The present results confirm predictions of computational modeling that an aryl substituent can be introduced at the 2-position in structure 3. The substituent is anticipated to project deeper into the binding site and provide opportunities for enhanced activity and selectivity. The most potent analog reported herein, 13, has a 4-hydroxyphenyl substituent and yields an IC(50) of 6 mu M for inhibition of phosphorylation by FGFR1 kinase. It was also found that the western anisole-containing substituent in 3 can be replaced by a propionic acid group with no loss in potency and with potentially significant gains in pharmacologically relevant properties. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2010.12.081
  • 作为产物:
    描述:
    8-(4-氯苯基)-1,4-二氧杂螺[4.5]癸烷-8-醇三氟乙酸 作用下, 反应 0.5h, 以96%的产率得到4-(p-chlorophenyl)-3-cyclohexen-1-one
    参考文献:
    名称:
    可见光介导的反式芳基环己烯的生成及其在环桥醚合成中的应用
    摘要:
    虽然可以通过顺式环己烯的紫外线照射获得,但反式环己烯迄今为止一直是由好奇心驱动的研究,主要是由于其寿命短,直到最近才被用于生产合成。在这里,我们提出了直接的条件,提供了获得一类反式芳基环己烯并证明它们在形成氧杂双环醚中的效用,否则相应的顺式环己烯是无法获得的。利用令人难以置信的 ca 的关键挑战。用于驱动合成的反式环己烯的 52 kcal/mol 应变能克服了其短寿命的问题。在这里,我们表明在异构化之前通过底物和反应伙伴之间的氢键进行预组织是克服反式环己烯固有的短寿命的可行策略。
    DOI:
    10.1021/jacs.8b04642
点击查看最新优质反应信息

文献信息

  • Desymmetrizing Isomerization of Alkene via Thiazolinyl Iminoquinoline Cobalt Catalysis
    作者:Wenbo Liu、Yushan Zheng、Yihui Mao、Jieping Chen、Xiang Ren、Zhaoyang Cheng、Zhan Lu
    DOI:10.1021/acs.orglett.1c04237
    日期:2022.2.11
    1-methylcyclohexene derivatives with good yields and enantioselectivities. A novel chiral thiazolinyl iminoquinoline ligand and its cobalt complex were designed and synthesized to control the establishment of tertiary or quaternary carbon centers at a remote position. This protocol is operationally simple, and a model for the stereochemical outcome has been proposed.
    我们报道了一种钴催化的外环烯烃去对称异构化,以产生具有良好收率和对映选择性的手性 1-甲基环己烯衍生物。设计并合成了一种新型手性噻唑啉基亚氨基喹啉配体及其钴配合物,以控制在偏远位置建立叔或季碳中心。该协议操作简单,并提出了立体化学结果的模型。
  • Synthesis of atovaquone
    作者:David R. Williams、Michael P. Clark
    DOI:10.1016/s0040-4039(98)01691-8
    日期:1998.10
    A short synthesis of atovaquone 1 is achieved via the radical coupling of the trans-1,4-sbustituted cyclohexyl mono-oxalate 2 and 2-chloronapthoquinone under phase transfer conditions. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • US3960961A
    申请人:——
    公开号:US3960961A
    公开(公告)日:1976-06-01
  • Aryl extensions of thienopyrimidinones as fibroblast growth factor receptor 1 kinase inhibitors
    作者:Anil R. Ekkati、Valsan Mandiyan、Krishna P. Ravindranathan、Jae H. Bae、Joseph Schlessinger、William L. Jorgensen
    DOI:10.1016/j.tetlet.2010.12.081
    日期:2011.4
    Optimization of thienopyrimidinone derivatives as FGFR1 kinase inhibitors is being pursued. The present results confirm predictions of computational modeling that an aryl substituent can be introduced at the 2-position in structure 3. The substituent is anticipated to project deeper into the binding site and provide opportunities for enhanced activity and selectivity. The most potent analog reported herein, 13, has a 4-hydroxyphenyl substituent and yields an IC(50) of 6 mu M for inhibition of phosphorylation by FGFR1 kinase. It was also found that the western anisole-containing substituent in 3 can be replaced by a propionic acid group with no loss in potency and with potentially significant gains in pharmacologically relevant properties. (C) 2010 Elsevier Ltd. All rights reserved.
  • Visible Light Mediated Generation of <i>trans</i>-Arylcyclohexenes and Their Utilization in the Synthesis of Cyclic Bridged Ethers
    作者:Jon I. Day、Kamaljeet Singh、Winston Trinh、Jimmie D. Weaver
    DOI:10.1021/jacs.8b04642
    日期:2018.8.8
    for productive synthesis. Herein, we present straightforward conditions that provide access to a class of trans-arylcyclohexenes and demonstrate their utility in the formation of oxabicyclic ethers, which are otherwise inaccessible from the corresponding cis-cyclohexene. A key challenge to utilizing the incredible ca. 52 kcal/mol strain energy of trans-cyclohexene to drive synthesis was overcoming
    虽然可以通过顺式环己烯的紫外线照射获得,但反式环己烯迄今为止一直是由好奇心驱动的研究,主要是由于其寿命短,直到最近才被用于生产合成。在这里,我们提出了直接的条件,提供了获得一类反式芳基环己烯并证明它们在形成氧杂双环醚中的效用,否则相应的顺式环己烯是无法获得的。利用令人难以置信的 ca 的关键挑战。用于驱动合成的反式环己烯的 52 kcal/mol 应变能克服了其短寿命的问题。在这里,我们表明在异构化之前通过底物和反应伙伴之间的氢键进行预组织是克服反式环己烯固有的短寿命的可行策略。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐